Antiverse, an AI-driven techbio company designing therapeutic antibodies for the most challenging disease targets, today ...

The ATTC platform integrates monoclonal antibodies with small-molecule inhibitor payloads to provide dual mechanisms of ...

Leveragen, Inc., a Boston-based biotechnology company advancing next-generation in vivo antibody discovery, announced today the issuance of a patent in Japan covering core innovations underlying its ...

The oncology monoclonal antibodies market presents opportunities through technological advancements, new product launches, ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Researchers engineer CAR-astrocytes to target and remove amyloid plaques in Alzheimer’s, showing a 50% reduction in brain waste with a single injection.

A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of ...

Biology researchers have developed a new antibody therapy that can neutralize a wide variety of HIV-1 strains. They found success in an unlikely source -- llamas. A research team at Georgia State ...

Tiny protein molecules derived from the blood of llamas and camels could be useful in treating brain disorders such as Alzheimer’s disease with fewer side effects, a new study says. These nanobodies ...

Nanobodies—tiny proteins derived from animals in the camelid family including camels, llamas, and alpacas—could be useful in treating brain disorders like schizophrenia and Alzheimer’s disease. In a ...